Malignant Thoracic Neoplasm — Trials

Malignant Thoracic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,496 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,773
Recruiting: 1,496
Ph III recruiting: 183
Growth YoY: +7.3%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,526)

clinicaltrialsPublishedShowing 1,151–1,154 of 1,154 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00265694	Random Trial for Elderly Patients With NSCLC	unknown	Phase 3	—	Inje UniversityOTHER	1	Dec 15, 2005	clinicaltrials
NCT00211952	Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients	suspended	Phase 3	542	Medical University of GdanskOTHER	1	Sep 21, 2005	clinicaltrials
NCT00175747